AIM-listed Advanced Medical Solutions reported that group revenue rose 53 per cent to 52.6m pounds in the year ended December 31st, supported by strong performance in its own brand business, Branded Direct. [6 Mar '13]
Advanced Medical Solutions: Investec reduces target price from 93p to 68p and downgrades from buy to hold. Numis downgrades to hold, while maintaining the target price at 165p. Canaccord Genuity moves target price from 93p to 90p and retains a buy recommendation. [13 Dec '12]
In the Financial Times, the Lex column urges caution on the apparent temptation of Nokia. The stock has collapsed 92pc in the last five years, hammered by the emergence of Apple's iPhone. In the last month though the stock has recovered somewhat, buoyed by Apple's victory in a US patent case against Samsung. Nokia doesn't appear to face the same pressure on its operating system as its competitors because it doesn't look or feel like iOS. On the other hand its latest offering, [6 Sep '12]
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.